Author

Martin Gaudier

Observed names: M Gaudier, MARTIN GAUDIER

Observed institution: Adocia (France)

OpenAlex ID: A5065525891

The Ultra-rapid Insulin (URI) BioChaperone Lispro (BCLIS) Shows Favorable Pharmacodynamics (PD) and Pharmacokinetics (PK) vs. Faster Aspart (FIA) and Insulin Aspart (ASP) in Insulin Pumps (CSII)

2018 · BRUCE W. BODE, OLIVER KLEIN, et al. · Diabetes · 12

BioChaperone Glucagon (BCG), a Stable Ready-to-Use Liquid Glucagon Formulation, Is Well Tolerated and Quickly Restores Euglycemia after Insulin-Induced Hypoglycemia

2018 · STANISLAV GLEZER, ULRIKE HOVELMANN, et al. · Diabetes · 6

150-OR: BioChaperone Pramlintide Insulin (BCPramIns), a New Co-Formulation of Pramlintide (PRAM) and Human Insulin (INS), Improves Postprandial Blood Glucose (BG) vs. Both Separate Injections of PRAM+INS and Insulin Lispro (LIS) in Subjects with T1D

2019 · GRÉGORY MEIFFREN, CYRIL SEROUSSI, et al. · Diabetes · 5

112-LB: ADO09, a Coformulation of Pramlintide (PRAM) and Insulin A21G, Improves Postprandial Glucose vs. Novolog in Type 1 Diabetes (T1D)

2020 · GRÉGORY MEIFFREN, GRIT ANDERSEN, et al. · Diabetes · 2

BioChaperone 222 (BC222), the New Excipient Enabling the Ultra-rapid BioChaperone Lispro (BCLIS) Formulation, Is Completely Absorbed and Rapidly Excreted after Subcutaneous (s.c.) Injection

2018 · GRÉGORY MEIFFREN, LEONA PLUM-MOERSCHEL, et al. · Diabetes · 2

1677-P: AdOral—A Versatile Platform for Improved Oral Peptide Absorption

2024 · ULYSSE NAESSENS, ALICE GUTJAHR, et al. · Diabetes · 1

197-OR: ADO09, a Coformulation of Insulin A21G and Pramlintide (Pram), Improves Blood Glucose Control and Reduces Body Weight in Subjects with T1D

2021 · GRÉGORY MEIFFREN, GRIT ANDERSEN, et al. · Diabetes · 1

Pooled Analysis of Clinical Trials Investigating the Pharmacokinetics (PK) of Ultra-rapid Insulin BioChaperone Lispro (BCLIS) vs. Lispro (LIS) in Subjects with Type 1 (T1D) and Type 2 (T2D) Diabetes

2018 · TIM HEISE, AYMERIC RANSON, et al. · Diabetes · 1

2008-P: BioChaperone Glucagon Exenatide (BC Glu Exe), a Stable Combination of Glucagon (Glu) and Exenatide (Exe) Achieved Larger Body Weight (BW) Loss than Exe Alone in DIO Mice

2019 · MARTIN GAUDIER, SANA HAKIM, et al. · Diabetes

Better Postprandial Glucose (PPG) Control with BioChaperone Combo (BC Combo) than with Lispro Mix25 (LMx) or Separate Glargine and Lispro (G+L) Administrations in Subjects with Type 2 Diabetes (T2DM)

2018 · TIM HEISE, LEONA PLUM MOERSCHEL, et al. · Diabetes

Ultra-rapid BioChaperone Lispro ameliorates postprandial blood glucose (PPBG) in a group with diabetes mellitus

2017 · G Andersen, G Meiffren, et al. · Diabetologie und Stoffwechsel

Works count: 11

Citation count: 30

H-index: 3

I10-index: 1